NJCKY(300826)2020-10-28 16:00Financial Performance - Operating revenue for the current period was CNY 79,821,393.38, a slight increase of 0.16% year-on-year[7] - Net profit attributable to shareholders decreased by 11.81% to CNY 6,173,197.41 compared to the same period last year[7] - Basic earnings per share decreased by 33.33% to CNY 0.08[7] - Diluted earnings per share decreased by 45.45% to CNY 0.06[7] - The weighted average return on equity was 0.63%, a decrease of 0.78% compared to the previous year[7] - Total operating revenue for Q3 2020 was CNY 79,821,393.38, a slight increase from CNY 79,696,243.66 in the previous period[35] - Net profit for Q3 2020 was CNY 6,546,588.59, down from CNY 7,086,135.89 in the same period last year[37] - The net profit for the current period is CNY 6,234,719.08, down from CNY 7,283,464.78 in the previous period, representing a decrease of approximately 14.4%[41] - The total comprehensive income for the current period is CNY 6,546,588.59, compared to CNY 7,086,135.89 in the previous period, reflecting a decrease of about 7.6%[41] - The net profit for the current period is CNY 33,931,796.74, down 19.5% from CNY 42,068,289.22 in the previous period[50] - The total comprehensive income attributable to the parent company is CNY 34,377,445.17, down 17.4% from CNY 41,586,383.78 in the previous period[48] Assets and Liabilities - Total assets increased by 43.04% to CNY 1,662,912,753.54 compared to the end of the previous year[7] - The company's total assets amounted to CNY 1,662,912,753.54, up from CNY 1,162,549,088.16 at the beginning of the year[28] - The company's total liabilities were CNY 675,622,402.63, compared to CNY 613,298,412.92 at the beginning of the year[29] - The total liabilities increased to CNY 666,114,842.59 from CNY 601,329,409.32, indicating a rise in financial obligations[33] - Total liabilities amounted to CNY 613,298,412.92, with current liabilities at CNY 602,298,412.92 and non-current liabilities at CNY 11,000,000.00[62] - The company's total equity reached CNY 549,250,675.24, including CNY 60,000,000.00 in share capital and CNY 184,591,011.94 in undistributed profits[62] Cash Flow - Net cash flow from operating activities was CNY 15,130,675.72, down 35.88% from the previous year[7] - The net cash flow from operating activities is negative CNY 43,569,112.37, worsening from negative CNY 22,444,160.45 in the previous period[53] - The net cash flow from financing activities was 390,472,203.30 CNY, a significant increase compared to -25,982,341.06 CNY in the previous period, reflecting improved financing conditions[54] - Total cash inflow from investment activities was 171,607,530.75 CNY, while cash outflow was 517,494,383.41 CNY, resulting in a net cash flow of -345,886,852.66 CNY[54] - The total cash and cash equivalents at the end of the period amounted to 164,218,952.54 CNY, up from 94,495,789.56 CNY in the previous period[54] Shareholder Information - Net assets attributable to shareholders rose by 80.37% to CNY 980,628,873.39 compared to the end of the previous year[7] - The total number of ordinary shareholders at the end of the reporting period was 12,221[11] - The company's equity capital increased to CNY 80,000,000.00, a 33.33% rise due to the public issuance of new shares[18] Inventory and Receivables - The company's accounts receivable at the end of the period reached CNY 12,183,128.40, an increase of 257.72% compared to the beginning of the year, primarily due to an increase in bank acceptance bills received[18] - Inventory at the end of the period was CNY 560,895,807.23, reflecting a 30.22% increase from the beginning of the year, driven by new business orders and backlog[18] - Accounts receivable rose to CNY 262,030,863.30 from CNY 250,489,808.49, indicating improved collection efforts[32] - Inventory increased significantly to CNY 553,762,020.73 from CNY 428,596,263.74, reflecting potential growth in sales or production[32] Expenses - Total operating costs increased to CNY 72,610,884.36 from CNY 66,173,906.58, with operating costs specifically rising from CNY 41,826,179.49 to CNY 51,684,397.22[36] - The company reported a decrease in research and development expenses from CNY 7,282,462.91 to CNY 5,171,787.95[36] - Research and development expenses for the current period are CNY 5,171,787.95, down from CNY 7,282,462.91 in the previous period, a reduction of approximately 29%[40] - The company's research and development expenses for the current period are CNY 16,170,866.90, a decrease of 19.5% from CNY 20,118,084.12 in the previous period[48] Future Outlook - Future outlook includes potential strategies for market expansion and new product development, although specific details were not provided in the report[41]